Triptan use patterns among migraine sufferers: results of the American migraine prevalence and prevention study (AMPP)

被引：0
|
作者：
Buse, D. C. [1 ]
Bigal, M. E. [2 ]
Serrano, D. [3 ]
Golden, W. M. [2 ]
Lipton, R. B. [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Merck Pharmaceut, Global Outcomes Res, Whitehouse Stn, NJ USA
[3] Vedanta Res, Res, Chapel Hill, NC USA
来源：
CEPHALALGIA | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, Richard B.
    Serrano, Daniel
    Nicholson, Robert A.
    Buse, Dawn C.
    Runken, M. Chris
    Reed, Michael L.
    HEADACHE, 2013, 53 (10): : 1548 - 1563
  • [2] Factors Associated with Triptan Use in Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention Study (AMPP)
    Chu, M. K.
    Buse, D. C.
    Bigal, M. E.
    Serrano, D.
    Lipton, R. B.
    HEADACHE, 2010, 50 : S25 - S26
  • [3] Acute medication use patterns in episodic migraine: results of the American migraine prevalence and prevention study (AMPP)
    Lipton, R. B.
    Buse, D. C.
    Serrano, D.
    Golden, W. M.
    Bigal, M. E.
    CEPHALALGIA, 2009, 29 : 17 - 17
  • [4] Acute Medication Use Patterns in Episodic Migraine: Results of the American Migraine Prevalence and Prevention Study (AMPP)
    Lipton, Richard B.
    Buse, Dawn C.
    Serrano, Daniel
    Golden, Wendy M.
    Chen, Ya-Ting
    Bigal, Marcelo
    NEUROLOGY, 2010, 74 (09) : A573 - A574
  • [5] Prevalence of migraine sufferers who are candidates for preventive therapy: Results from the American Migraine Prevalence and Prevention (AMPP) study
    Silberstein, S
    Diamond, S
    Loder, E
    Reed, ML
    Lipton, RB
    HEADACHE, 2005, 45 (06): : 770 - 771
  • [6] Employment and work impact of headache among episodic and chronic migraine sufferers: results of the American migraine prevalence and prevention (AMPP) study
    Stewart, W. F.
    Woods, G. C.
    Manack, A.
    Buse, D. C.
    Varon, S. F.
    Scher, A., I
    Serrano, D.
    Reed, M.
    Lipton, R. B.
    CEPHALALGIA, 2009, 29 : 57 - 58
  • [7] Migraine prevention patterns in a community sample: Results from the American Migraine Prevalence and Prevention (AMPP) study
    Lipton, RB
    Diamond, M
    Freitag, FG
    Bigal, M
    Stewart, WF
    Reed, ML
    HEADACHE, 2005, 45 (06): : 792 - 792
  • [8] Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
    Lipton, R. B.
    Manack, A. N.
    Serrano, D.
    Buse, D. C.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [9] Probable migraine in the United States: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Silberstein, S.
    Loder, E.
    Diamond, S.
    Reed, M. L.
    Bigal, M. E.
    Lipton, R. B.
    CEPHALALGIA, 2007, 27 (03) : 220 - 229
  • [10] The Impact of Triptan Use and Allodynia on Initial and Sustained Response to Medication in Episodic Migraine (EM): Results from American Migraine Prevalence and Prevention Study (AMPP)
    Munjal, S.
    Reed, M. L.
    Buse, D. C.
    Bennett, A.
    Fanning, K. M.
    Lipton, R. B.
    HEADACHE, 2016, 56 : 15 - 15
12345